唾液抗SARS-CoV-2 RBD IgG检测:高灵敏方法验证及采样方法与蛋白校正的影响
研究开发并验证了一种基于放大发光邻近均相技术的高灵敏两步夹心免疫分析法,用于检测唾液中的抗SARS-CoV-2 RBD IgG。采用疫苗接种后不同时间的配对唾液和血清样本,评估了采样条件(刺激唾液与被动流涎)和总蛋白校正对唾液抗体检测能力的影响。结果显示唾液抗体浓度低于血清但动力学相似,被动流涎且不经蛋白校正时相关性更高;该方法分析性能良好,但在免疫应答早期和抗体下降阶段唾液敏感性可能低于血清。
要点
- 开发的高灵敏两步夹心免疫分析法可准确测量疫苗接种者唾液中的抗体浓度。
- 唾液抗体浓度低于血清但动力学相似,被动流涎且不校正蛋白时与血清相关性更高。
- 唾液在免疫应答早期及抗体下降后敏感性可能低于血清。
核心结论
- 所开发方法分析性能良好,可准确测量疫苗接种者唾液中的抗体浓度。
- 唾液在免疫应答初期及抗体应答下降后敏感性可能低于血清。
研究设计与样本
- 开发基于放大发光邻近均相技术的两步夹心免疫分析法并进行分析验证。
- 使用疫苗接种后不同时间的配对唾液和血清样本,评估采样条件及总蛋白校正的影响。
主要发现
- 唾液抗体浓度低于血清,但两者动力学相似。
- 被动流涎获取唾液且结果不经蛋白校正时,唾液与血清相关性更高。
临床怎么用
- 唾液可作为疫苗接种后抗体监测的替代样本,但需注意免疫早期和抗体下降阶段的敏感性限制。
- 建议采用被动流涎采样且不进行总蛋白校正以提高与血清的相关性。
局限性
- 唾液在免疫应答早期和抗体下降后敏感性可能低于血清。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To develop and evaluate a new highly sensitive assay to detect IgG anti-SARS-CoV-2 RBD in saliva samples. METHODS: A two-step sandwich type immunoassay based on the amplified luminescent proximity homogeneous technology was developed and an analytical validation was performed. As a part of this validation, the influence of factors, such as different sampling conditions (stimulated saliva and passive drool) and the correction of values by total protein content, in the ability of saliva to detect increases in antibodies after an immune stimulus and be an alternative to serum, was evaluated. For this purpose, paired samples of saliva and serum at different times after vaccination were used. RESULTS: Saliva concentrations were lower than serum, but both fluids showed similar kinetics, with higher correlations when saliva was obtained by passive flow and the results were not corrected by protein. CONCLUSIONS: The developed method showed a good analytical performance and can properly measure antibody concentrations in saliva of vaccinated individuals. However, saliva could have a lower sensitivity compared to serum at initial stages of the immune response and also when the antibody response decreased after a stimulus.
引用
- Martínez-Subiela S, Franco-Martínez L, Rubio CP, et al. Measurement of anti SARS-CoV-2 RBD IgG in saliva: validation of a highly sensitive assay and effects of the sampling collection method and correction by protein. Clin Chem Lab Med. 2022. PMID: 35848513. doi:10.1515/cclm-2022-0418
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。